The U.S. Supreme Court today heard arguments in a case that will further refine to what extent the makers of generic pharmaceutical drugs can be sued in state court. In Bartlett v. Mutual Pharmaceuticals, the justices will decide if federal law that governs the design of generic drugs preempts state consumer protection laws in cases where the drugs injure patients. Karen Bartlett was blinded and suffered horrific skin problems in 2004, with two-thirds of her body becoming an open wound, …
Read More Leave a Comment





